abstract |
The present invention relates to the compound of the following formula (I), wherein B, X, R 3 , L 0 , L 1 , L 2 , R 2 , R 1 and R C are defined in the description. These compounds can be used as inhibitors of HCV NS3 protease to treat hepatitis C virus infection. It also relates to compositions comprising said compounds, uses and preparations thereof, and intermediate compounds. |